Clinical Trial Update: International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device [Phase 3]

View source ↗

Summary

A Phase 3 international trial evaluating whether the AdreView heart function scan can identify heart failure patients who benefit from implanted medical devices…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• ADREVIEW (IOBENGUANE I-123)

Snippet

Sponsor: GE Healthcare | Conditions: Heart Failure | Phase 3 | Status: TERMINATED | Results posted: 2019-05-22